Skip to content

Clinical trials

Aortic Valve Stenosis trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Aortic Valve Stenosis Phase: Not applicable Country / region: China Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20142
20172
20184
20191
20203
20213
20221
20234
20247
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting14
Unknown status7
Completed5
Enrolling by invitation4
Not yet recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Second Affiliated Hospital, Zhejiang University, School of Medicine4
China National Center for Cardiovascular Diseases3
Peijia Medical Technology (Suzhou) Co., Ltd.3
Shanghai MicroPort CardioFlow Medtech Co., Ltd.3
Chinese Academy of Medical Sciences, Fuwai Hospital2
Edwards Lifesciences2
Shanghai NewMed Medical Co., Ltd.2
Xijing Hospital2
Beijing Balance Medical Technology Co., Ltd1
Boston Scientific Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Aortic Valve Stenosis34
Aortic Valve Insufficiency5
Aortic Valve Disease4
Cardiovascular Diseases2
Heart Valve Diseases2
Aneurysm, Ascending Aorta1
Bicuspid Aortic Valve Disease1
Calcinosis1
Heart Diseases1
Mitral Valve Insufficiency1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.